Stockscreener 앱 받기
2.82
1.40%
-0.04
시간 외 거래:
2.84
0.02
+0.71%
전일 마감가:
$2.86
열려 있는:
$2.84
하루 거래량:
65,306
Relative Volume:
0.11
시가총액:
$178.48M
수익:
-
순이익/손실:
$-45.08M
주가수익비율:
-3.863
EPS:
-0.73
순현금흐름:
$-33.68M
1주 성능:
-1.05%
1개월 성능:
+13.71%
6개월 성능:
+129.27%
1년 성능:
+8.88%
1일 변동 폭
$2.8102
$2.865
1주일 범위
$2.54
$3.18
52주 변동 폭
$0.726
$3.9035
Galectin Therapeutics Inc Stock (GALT) Company Profile
명칭
Galectin Therapeutics Inc
전화
678-620-3186
주소
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA
GALT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GALT
Galectin Therapeutics Inc
|
2.82 | 181.01M | 0 | -45.08M | -33.68M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-17 | 재개 | H.C. Wainwright | Buy |
| 2020-08-13 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-13 | 개시 | B. Riley FBR | Buy |
| 2017-12-07 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-28 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-19 | 개시 | ROTH Capital | Buy |
| 2017-03-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2016-10-03 | 다운그레이드 | FBR & Co. | Outperform → Mkt Perform |
| 2016-09-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2016-09-28 | 다운그레이드 | ROTH Capital | Buy → Sell |
| 2016-03-28 | 재개 | H.C. Wainwright | Buy |
| 2015-09-21 | 개시 | H.C. Wainwright | Buy |
| 2014-08-01 | 다운그레이드 | Aegis Capital | Buy → Hold |
| 2014-07-30 | 재확인 | MLV & Co | Buy |
| 2014-07-29 | 재확인 | MLV & Co | Buy |
| 2014-04-02 | 재확인 | MLV & Co | Buy |
| 2014-02-10 | 재확인 | Aegis Capital | Buy |
| 2014-01-09 | 재확인 | Aegis Capital | Buy |
| 2013-12-03 | 개시 | MLV & Co | Buy |
| 2013-08-19 | 재확인 | Aegis Capital | Buy |
모두보기
Galectin Therapeutics Inc 주식(GALT)의 최신 뉴스
Galectin Therapeutics Inc. Stock Analysis and ForecastFree Trend-Following Techniques - Autocar Professional
What drives Galectin Therapeutics Inc. stock priceRapidly growing investment returns - jammulinksnews.com
What analysts say about Galectin Therapeutics Inc. stockAccelerated wealth building - jammulinksnews.com
Is Galectin Therapeutics Inc. a good long term investmentAccelerated wealth building - jammulinksnews.com
Galectin Therapeutics (NASDAQ:GALT) Stock Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Director’s Bold Move: Major Stock Purchase at Galectin Therapeutics! - TipRanks
Freeman buys Galectin therapeutics (GALT) stock worth $14,495 - Investing.com Australia
Freeman buys Galectin therapeutics (GALT) stock worth $14,495 By Investing.com - Investing.com Nigeria
What makes Galectin Therapeutics Inc. stock price move sharplyMarket Ready Callouts - Newser
Why Galectin Therapeutics Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
Why Did Galectin Therapeutics (GALT) Soar 14.04%? - AInvest
How Galectin Therapeutics Inc. stock performs during market volatilityFree Discussion Group - Newser
Galectin Therapeutics (NASDAQ:GALT) Share Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Galectin Therapeutics announces new $10 million credit line from Richard Uihlein - MSN
Galectin Therapeutics Secures $10M Credit Line for Growth - The Globe and Mail
Galectin Therapeutics secures $10 million credit line from board chairman By Investing.com - Investing.com South Africa
Galectin Therapeutics secures $10 million credit line from board chairman - Investing.com Australia
Galectin Therapeutics Inc. announced that it expects to receive $10 million in funding - MarketScreener
Galectin Therapeutics Secures Additional $10 million Credit Line - MarketScreener
ALVO 6-K: Alvotech discloses Ivers-Lee Group acquisition | GALT SEC FilingForm 8-K - Stock Titan
Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026 - TradingView
Board Chairman Injects $10M Into Galectin's MASH Treatment Program: Extended Funding Through 2026 - Stock Titan
Galectin Therapeutics (NASDAQ:GALT) Share Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Galectin Therapeutics Inc.'s (NASDAQ:GALT) stock price dropped 13% last week; individual investors would not be happy - simplywall.st
Galectin Therapeutics (NASDAQ:GALT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
What is HC Wainwright's Estimate for GALT Q2 Earnings? - MarketBeat
Equities Analysts Issue Forecasts for GALT Q2 Earnings - Defense World
Galectin Therapeutics Inc. (NASDAQ:GALT) Stock Holdings Lifted by Wealth Enhancement Advisory Services LLC - Defense World
Galectin Therapeutics (NASDAQ:GALT) Now Covered by Analysts at HC Wainwright - Defense World
Galectin Therapeutics Soars 22% Amid Technical Puzzles and Retail Surge - AInvest
Galectin Therapeutics stock rating initiated at buy by H.C. Wainwright - Investing.com Nigeria
Analyst Forecast For Galectin Therapeutics Inc (NASDAQ: GALT) - Stocksregister
Galectin Therapeutics (GALT) Receives Buy Rating from H.C. Wainw - GuruFocus
HC Wainwright Initiates Coverage on Galectin Therapeutics (NASDAQ:GALT) - MarketBeat
HC Wainwright & Co. Initiates Coverage with Buy Rating on GALT | - GuruFocus
Galectin Therapeutics (GALT) Receives Buy Rating from H.C. Wainwright | GALT Stock News - GuruFocus
Transcript : Galectin Therapeutics Inc.Special Call - MarketScreener
Galectin Therapeutics Inc (GALT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.91%
0.25%
자본화:
|
볼륨(24시간):